These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 37474114)

  • 1. Structure-Activity Assessment and In-Depth Analysis of Biased Agonism in a Set of Phenylalkylamine 5-HT
    Pottie E; Poulie CBM; Simon IA; Harpsøe K; D'Andrea L; Komarov IV; Gloriam DE; Jensen AA; Kristensen JL; Stove CP
    ACS Chem Neurosci; 2023 Aug; 14(15):2727-2742. PubMed ID: 37474114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of psychedelic new psychoactive substances (NPS) showing biased agonism at the 5-HT
    Pottie E; Dedecker P; Stove CP
    Biochem Pharmacol; 2020 Dec; 182():114251. PubMed ID: 32998000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of β-Arrestin-Biased 25CN-NBOH-Derived 5-HT
    Poulie CBM; Pottie E; Simon IA; Harpsøe K; D'Andrea L; Komarov IV; Gloriam DE; Jensen AA; Stove CP; Kristensen JL
    J Med Chem; 2022 Sep; 65(18):12031-12043. PubMed ID: 36099411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological Mechanism of the Non-hallucinogenic 5-HT
    Cunningham MJ; Bock HA; Serrano IC; Bechand B; Vidyadhara DJ; Bonniwell EM; Lankri D; Duggan P; Nazarova AL; Cao AB; Calkins MM; Khirsariya P; Hwu C; Katritch V; Chandra SS; McCorvy JD; Sames D
    ACS Chem Neurosci; 2023 Jan; 14(1):119-135. PubMed ID: 36521179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurochemical pharmacology of psychoactive substituted N-benzylphenethylamines: High potency agonists at 5-HT
    Eshleman AJ; Wolfrum KM; Reed JF; Kim SO; Johnson RA; Janowsky A
    Biochem Pharmacol; 2018 Dec; 158():27-34. PubMed ID: 30261175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hallucinogens and Serotonin 5-HT
    López-Giménez JF; González-Maeso J
    Curr Top Behav Neurosci; 2018; 36():45-73. PubMed ID: 28677096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemistry and Structure-Activity Relationships of Psychedelics.
    Nichols DE
    Curr Top Behav Neurosci; 2018; 36():1-43. PubMed ID: 28401524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT
    de la Fuente Revenga M; Jaster AM; McGinn J; Silva G; Saha S; González-Maeso J
    ACS Chem Neurosci; 2022 Aug; 13(16):2436-2448. PubMed ID: 35900876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes.
    Borroto-Escuela DO; Romero-Fernandez W; Narvaez M; Oflijan J; Agnati LF; Fuxe K
    Biochem Biophys Res Commun; 2014 Jan; 443(1):278-84. PubMed ID: 24309097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Bulky
    Soares BA; Yempala T; Martínez-Afani D; Acevedo-Fuentes W; Brea J; Loza MI; Cimadevila M; Cassels BK
    ACS Chem Neurosci; 2024 Feb; 15(3):608-616. PubMed ID: 38241462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD).
    Brandt SD; Kavanagh PV; Westphal F; Stratford A; Elliott SP; Hoang K; Wallach J; Halberstadt AL
    Drug Test Anal; 2016 Sep; 8(9):891-902. PubMed ID: 26456305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro structure-activity relationship determination of 30 psychedelic new psychoactive substances by means of β-arrestin 2 recruitment to the serotonin 2A receptor.
    Pottie E; Cannaert A; Stove CP
    Arch Toxicol; 2020 Oct; 94(10):3449-3460. PubMed ID: 32627074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD).
    Halberstadt AL; Chatha M; Klein AK; McCorvy JD; Meyer MR; Wagmann L; Stratford A; Brandt SD
    Neuropharmacology; 2020 Aug; 172():107856. PubMed ID: 31756337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro assays for the functional characterization of (psychedelic) substances at the serotonin receptor 5-HT
    Pottie E; Stove CP
    J Neurochem; 2022 Jul; 162(1):39-59. PubMed ID: 34978711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Pharmacological Effects of Lisuride and Lysergic Acid Diethylamide Revisited.
    Glatfelter GC; Pottie E; Partilla JS; Stove CP; Baumann MH
    ACS Pharmacol Transl Sci; 2024 Mar; 7(3):641-653. PubMed ID: 38481684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of 5-HT
    Wallach J; Cao AB; Calkins MM; Heim AJ; Lanham JK; Bonniwell EM; Hennessey JJ; Bock HA; Anderson EI; Sherwood AM; Morris H; de Klein R; Klein AK; Cuccurazzu B; Gamrat J; Fannana T; Zauhar R; Halberstadt AL; McCorvy JD
    Nat Commun; 2023 Dec; 14(1):8221. PubMed ID: 38102107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the 5-HT
    Jaster AM; Elder H; Marsh SA; de la Fuente Revenga M; Negus SS; González-Maeso J
    Psychopharmacology (Berl); 2022 Jun; 239(6):1665-1677. PubMed ID: 35233648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens.
    Halberstadt AL
    Curr Top Behav Neurosci; 2017; 32():283-311. PubMed ID: 28097528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs).
    Rickli A; Luethi D; Reinisch J; Buchy D; Hoener MC; Liechti ME
    Neuropharmacology; 2015 Dec; 99():546-53. PubMed ID: 26318099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychedelics and the human receptorome.
    Ray TS
    PLoS One; 2010 Feb; 5(2):e9019. PubMed ID: 20126400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.